Overview
Bronchospasm caused by drugs can occur as an adverse reaction, particularly during procedures like bronchoscopy, leading to respiratory distress and discomfort 1.Diagnosis
Monitor respiratory signs: wheezing, use of accessory muscles, decreased breath sounds 1.
Assess patient history for recent drug exposure 1.
Vital signs monitoring: tachycardia, hypertension, tachypnea 1.
Consider pulmonary function tests if bronchospasm is suspected outside procedural contexts 1.Management
First-line treatments:
- Sedative-opioid combination: Midazolam and pethidine for procedural sedation to reduce bronchospasm triggers 1.
Adjunctive treatments:
- Bronchodilators: Albuterol or ipratropium bromide via nebulizer to relieve bronchospasm 1.
- Supportive care: Oxygen supplementation, monitoring for respiratory status 1.Special Populations
Pediatrics: Specific dosing and monitoring protocols for sedatives and bronchodilators are crucial but not detailed in provided abstracts 1.
Elderly: Increased vigilance for adverse reactions to sedatives and opioids; careful titration of doses 1.
Comorbidities: Patients with respiratory conditions may require preemptive bronchodilator therapy before procedures 1.Key Recommendations
Utilize a combination of midazolam and pethidine for sedation during bronchoscopy to potentially improve patient acceptance and reduce procedural distress (Evidence: Moderate 1).
Administer bronchodilators such as albuterol or ipratropium bromide to patients exhibiting signs of bronchospasm post-procedurally (Evidence: Moderate 1).
Tailor sedation dosing carefully in elderly patients to minimize adverse respiratory events (Evidence: Expert opinion 1).References
1 Katsurada M, Tachihara M, Katsurada N, Takata N, Sato H, Mimura C et al.. Randomized single-blind comparative study of the midazolam/pethidine combination and midazolam alone during bronchoscopy. BMC cancer 2022. link